Aortech Share Discussion Threads

[coolhandfluke] 02/2/2018 13:28

Problem is the medical world still lags behind. My doctor said I needed a pacemaker and gave me an Ethiopian!

[petebarnes1] 02/2/2018 12:32

agreed davisc5 this will not go back

[davisc5] 02/2/2018 12:22

Lol, u hope

[coiin stein] 02/2/2018 11:38

AOR has had a nice technical bounce, but will now drift back until news arrives, so I wouldn't be that surprised to see 35p again.

[cocker] 02/2/2018 11:20

Since the results & the litigation issue, AOR share price has risen to possibly fair value. Now it's a case of high risk,high reward. Like I said before,Bill will need to pull something big out of the hat for this to have the legs for a rerating. Let's hope the air of optimism is fulfilled.

[petebarnes1] 02/2/2018 11:05

well i am in at 57p so hope it turns right

[k1ngkonggb] 02/2/2018 09:42

I suspect that this might try and retrace back to the early 40's as it has a habit of doing this. Will risk the wait until it get's to that price before buying more, although I may miss the boat so will be prepared to pay higher.

[turbotrader2] 02/2/2018 09:38

Buying opp

[investordave] 02/2/2018 08:40

What makes you think there might be news next week Stig? Just a hunch?

[the stigologist] 01/2/2018 21:14

Constructive chart, consolidating nicely just below 52 week closing highs

Strong possibility of news next week

So a little bit more sideways tomorrow and maybe Monday is just the ticket

[coolhandfluke] 01/2/2018 13:06

For a second this morning I got a nice surprise when I touched AOR to go to the 2nd screen and saw 69p. I quickly realised I had touched the one below, Alliance Pharma. Still, could have been worse. If I had touched the one above, Laura Ashley, I would have seen 6.6p and fainted.

[petebarnes1] 01/2/2018 12:18

I am in for one reason to gain expected re rate and true value , simple and its coming.

[petebarnes1] 01/2/2018 12:09

massive undervalue here, and with al happening soon would not want to be out of this one at this time.

[turbotrader2] 01/2/2018 11:42

Nah - news soon imho

[coolhandfluke] 01/2/2018 10:31

The most recent chart suggests we are going back to 37.5p after too days of up. Then up again.

[the stigologist] 01/2/2018 10:05

This is the groundfloor and I think we're very privileged to be able to buy here.

I expect Market to get a wake up call soon and then it will be impossible to buy sub 200p I reckon

[the stigologist] 01/2/2018 08:14

Quite happy to trust Biomerics and the Insiders with large stakes on that score. I don't know you from Adam.

[spawny100] 01/2/2018 08:07

That's very much assuming that the IP that Aortech hold is indeed THAT desirable and superior to other competitors on the market Stig. I'm doing some digging to try to establish this potential advantage at present as I need some reassurance that there are not other products on the market with much the same properties as Elast-Eon etc.

[bones] 01/2/2018 07:58

Ewan, I follow your argument but I would always want at least a small stake in place even then to benefit from the big rise should that happen and then do the bigger top up. As it is, I feel a bit more confident! I hope it is well placed.

[ewanwhose] 01/2/2018 06:39

Bones,Thanks for the reply. You outline the case why I bought in, as in recent RNS etc.Looking more fundamentally, I would like to see some evidence they can deliver from where they are before investing rather than punting. To put it another way, I would rather pay more later for a reduction in risk.

[the stigologist] 01/2/2018 00:00

Certainly in one of those Biomerics Press Releases above they extol the virtue of Vertical Integration.

If Biomerics are prepared to pay $30m just for a new HQ building I imagine they might cough up that sort of ball park figure to tie up this IP

For all we know they may have made informal approached to AOR BoD to the effect 'say if we did bid, what sort of ballpark figure would you be looking for'

In this scenario I imagine Biomerics might be thinking $30m whilst AorTech BoD $300m.

It's a case of them maybe coming to an arrangement at some point and partly it will depend on credibility and deliverability of this Strategic Plan

All just me fantasising

[bones] 31/1/2018 23:54

Ewan, sure it's small, less than £3m market cap all in. So small that I own 2% and I'm not a big player believe me!The company has been blindsided and distracted from its business due to its long running spat with the ex-CEO. No wonder it's not got far lately.Now all that has changed. There was a confidential legal settlement that AOR say they are satisfied with. I'd like to think that means favourable terms were arrived at. Certainly the implication is that the cash position will improve.My belief is that, unlike the last 4 years when the legal wrangling took place, AOR now can:- exploit its IP to the max- release its management expertise to develop its business IP- review existing and lapsed licences and work on improving its market pricing- strengthen its ties with Biomerics - work on breast/heart products with renewed vigourHope to see much of this spelled out in the promised strategic plan. Speculatively, I ask myself whether Biomerics could take a small stake in exchange for a healthy R&D budget? That would certainly release value.All just me thinking out loud.